NCT04851119 2026-02-24
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT03697577 2026-01-23
CDK and Body Composition Study
Montefiore Medical Center
Recruiting
NCT05838716 2026-01-15
ViPER
University of Rochester
Phase 3 Recruiting
NCT06039371 2026-01-14
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
University of Washington
Phase 2 Recruiting
NCT05893940 2025-12-03
Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients
Roswell Park Cancer Institute
Phase NA Recruiting
NCT05876923 2025-11-10
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
Mayo Clinic
Phase NA Recruiting